SCOPUS 정보 검색 플랫폼

Current Opinion in Pharmacology

Volumn 2, Issue 2, 2002, Pages 177-181

Therapeutic strategies to halt renal fibrosis

(3) Yu, Ling a Noble, Nancy A a Border, Wayne A a

a UNIVERSITY OF UTAH (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIFIBROTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CAPTOPRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CREATININE; CYTOKINE; CYTOKINE ANTIBODY; DECORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; FIBRONECTIN; IRBESARTAN; LEPTIN RECEPTOR; LOSARTAN; MESSENGER RNA; MONOCLONAL ANTIBODY; PLATELET DERIVED GROWTH FACTOR; RAMIPRIL; STREPTOZOCIN; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNINDEXED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY FIBROSIS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0036534575 PISSN: 14714892 EISSN: None Source Type: Journal
DOI: 10.1016/S1471-4892(02)00144-3 Document Type: Review

Times cited : (44)

References (47)

1
- 33644589919
- Epidemiology of end-stage renal disease: International comparisions of renal replacement therapy
- (2000) Kidney Int , vol.57 , pp. 39-45
- Schena, F.P.¹

2
- 0023906655
- The progression of renal disease
- (1988) New. Engl. J. Med , vol.318 , pp. 1657-1666
- Klahr, S.¹ Schreiner, G.² Ichikawa, I.³

3
- 0028109801
- Transforming growth factor β in tissue fibrosis
- (1994) New Engl. J. Med , vol.331 , pp. 1286-1292
- Border, W.A.¹ Noble, N.A.²

4
- 0030924446
- Angiotensin II in renal fibrosis: Should TGF-beta rather than blood pressure be the therapeutic target?
- (1997) Semin. Nephrol , vol.17 , pp. 455-466
- Noble, N.A.¹ Border, W.A.²

5
- 0035462888
- Angiotensin II and renal fibrosis
- (2001) Hypertension , vol.38 , pp. 635-638
- Mezzano, S.A.¹ Ruiz-Ortega, M.² Egido, J.³

6
- 0027517659
- The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
- The collaborative study group
- (1993) New Engl. J. Med , vol.329 , pp. 1456-1462
- Lewis, E.J.¹ Hunsicker, L.G.² Bain, R.P.³ Rohde, R.D.⁴

7
- 0342636985
- Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
- The Microalbuminuria Captopril Study Group:
- (1996) Diabetologia , vol.39 , pp. 587-593

8
- 0027517013
- Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
- (1993) Ann. Intern. Med , vol.118 , pp. 577-581
- Ravid, M.¹ Savin, H.² Jutrin, I.³ Bental, T.⁴ Katz, B.⁵ Lishner, M.⁶

9
- 0034688194
- Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
- (2000) New Engl. J. Med , vol.342 , pp. 145-153
- Yusuf, S.¹ Sleight, P.² Pogue, J.³ Bosch, J.⁴ Davies, R.⁵ Dagenais, G.⁶

10
- 0035922441
- Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
- (2001) New. Engl. J. Med , vol.345 , pp. 861-869
- Brenner, B.M.¹ Cooper, M.E.² de Zeeuw, D.³ Keane, W.F.⁴ Mitch, W.E.⁵ Parving, H.H.⁶ Remuzzi, G.⁷ Snapinn, S.M.⁸ Zhang, Z.⁹ Shahinfar, S.¹⁰

11
- 0035922447
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
- (2001) New Engl. J. Med , vol.345 , pp. 851-860
- Lewis, E.J.¹ Hunsicker, L.G.² Clarke, W.R.³ Berl, T.⁴ Pohl, M.A.⁵ Lewis, J.B.⁶ Ritz, E.⁷ Atkins, R.C.⁸ Rohde, R.⁹ Raz, I.¹⁰

12
- 15844368318
- Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency
- The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency study group
- (1996) New Engl. J. Med , vol.334 , pp. 939-945
- Maschio, G.¹ Alberti, D.² Janin, G.³ Locatelli, F.⁴ Mann, J.F.⁵ Motolese, M.⁶ Ponticelli, C.⁷ Ritz, E.⁸ Zucchelli, P.⁹

13
- 0030604561
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
- The GISEN Group (Gruppo Italiano di Studi Epidemiologic in Nefrologia):
- (1997) Lancet , vol.349 , pp. 1857-1863

14
- 0033620788
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
- (1999) Lancet , vol.354 , pp. 359-364
- Ruggenenti, P.¹ Perna, A.² Gherardi, G.³ Garini, G.⁴ Zoccali, C.⁵ Salvadori, M.⁶ Scolari, F.⁷ Schena, F.P.⁸ Remuzzi, G.⁹

15
- 0031727915
- Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade
- (1998) Kidney Int , vol.54 , pp. 1570-1580
- Peters, H.¹ Border, W.A.² Noble, N.A.³

16
- 0033736396
- Transforming growth factor-β1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction
- (2000) Kidney Int , vol.58 , pp. 1885-1892
- Isaka, Y.¹ Tsujie, M.² Ando, Y.³ Nakamura, H.⁴ Kaneda, Y.⁵ Imai, E.⁶ Hori, M.⁷

17
- 0002779849
- Therapy with antisense TGF-β1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice
- (2000) Am. J. Physiol. Renal. Physiol , vol.278
- Han, D.C.¹ Hoffman, B.B.² Hong, S.W.³ Guo, J.⁴ Ziyadeh, F.N.⁵

18
- 0032910706
- Gene therapy by transforming growth factor-β receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis
- (1999) Kidney Int , vol.55 , pp. 465-475
- Isaka, Y.¹ Akagi, Y.² Ando, Y.³ Tsujie, M.⁴ Sudo, T.⁵ Ohno, N.⁶ Border, W.A.⁷ Noble, N.A.⁸ Kaneda, Y.⁹ Hori, M.¹⁰

19
- 0035310360
- Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent
- (2001) Biochem. J , vol.355 , pp. 215-222
- Vilchis-Landeros, M.M.¹ Montiel, J.L.² Mendoza, V.³ Mendoza-Hernandez, G.⁴ Lopez-Casillas, F.⁵

20
- 0026676859
- Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease
- (1992) Nature , vol.360 , pp. 361-364
- Border, W.A.¹ Noble, N.A.² Yamamoto, T.³ Harper, J.R.⁴ Yamaguchi, Y.⁵ Pierschbacher, M.D.⁶ Ruoslahti, E.⁷

21
- 0029905441
- Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
- (1996) Nat. Med , vol.2 , pp. 418-423
- Isaka, Y.¹ Brees, D.K.² Ikegaya, K.³ Kaneda, Y.⁴ Imai, E.⁵ Noble, N.A.⁶ Border, W.A.⁷

22
- 0029897379
- The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice
- (1996) Proc. Natl. Acad. Sci. USA , vol.93 , pp. 5877-5882
- Bottinger, E.P.¹ Factor, V.M.² Tsang, M.L.³ Weatherbee, J.A.⁴ Kopp, J.B.⁵ Qian, S.W.⁶ Wakefield, L.M.⁷ Roberts, A.B.⁸ Thorgeirsson, S.S.⁹ Sporn, M.B.¹⁰

23
- 0035865213
- Blockade of TGF-β signaling in T cells prevents the development of experimental glomerulonephritis
- (2001) J. Immunol , vol.166 , pp. 2818-2823
- Kanamaru, Y.¹ Nakao, A.² Mamura, M.³ Suzuki, Y.⁴ Shirato, I.⁵ Okumura, K.⁶ Tomino, Y.⁷ Ra, C.⁸

24
- 0035088456
- Thrombospondin-1 is the key activator of TGF-β1 in human mesangial cells exposed to high glucose
- (2001) J. Am. Soc. Nephrol , vol.12 , pp. 703-712
- Yevdokimova, N.¹ Wahab, N.A.² Mason, R.M.³

25
- 0025277164
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1
- (1990) Nature , vol.346 , pp. 371-374
- Border, W.A.¹ Okuda, S.² Languino, L.R.³ Sporn, M.B.⁴ Ruoslahti, E.⁵

26
- 0029924637
- Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice
- (1996) Diabetes , vol.45 , pp. 522-530
- Sharma, K.¹ Jin, Y.² Guo, J.³ Ziyadeh, F.N.⁴

27
- 0034608948
- Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
- (2000) Proc. Natl. Acad. Sci. USA , vol.97 , pp. 8015-8020
- Ziyadeh, F.N.¹ Hoffman, B.B.² Han, D.C.³ Iglesias-De La Cruz, M.C.⁴ Hong, S.W.⁵ Isono, M.⁶ Chen, S.⁷ McGowan, T.A.⁸ Sharma, K.⁹

28
- 0033667371
- Antibody to transforming growth factor-β ameliorates tubular apoptosis in unilateral ureteral obstruction
- (2000) Kidney Int , vol.58 , pp. 2301-2313
- Miyajima, A.¹ Chen, J.² Lawrence, C.³ Ledbetter, S.⁴ Soslow, R.A.⁵ Stern, J.⁶ Jha, S.⁷ Pigato, J.⁸ Lemer, M.L.⁹ Poppas, D.P.¹⁰

29
- 0034827951
- Transforming growth factor-β2 antibody attenuates fibrosis in the experimental diabetic rat kidney
- (2001) J. Endocrinol , vol.170 , pp. 647-651
- Hill, C.¹ Flyvbjerg, A.² Rasch, R.³ Bak, M.⁴ Logan, A.⁵

30
- 0027425864
- Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice
- (1993) Thorax , vol.48 , pp. 959-966
- Giri, S.N.¹ Hyde, D.M.² Hollinger, M.A.³

31
- 0028230233
- Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model
- (1994) J. Clin. Invest , vol.93 , pp. 1172-1178
- Wolf, Y.G.¹ Rasmussen, L.M.² Ruoslahti, E.³

32
- 0026505458
- Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
- (1992) Lancet , vol.339 , pp. 213-214
- Shah, M.¹ Foreman, D.M.² Ferguson, M.W.J.³

33
- 0033017344
- Anti-sclerotic effect of transforming growth factor-β antibody in a mouse model of bleomycin-induced scleroderma
- (1999) Clin. Immunol , vol.92 , pp. 6-13
- Yamamoto, T.¹ Takagawa, S.² Katayama, I.³ Nishioka, K.⁴

34
- 0033571072
- Anti-TGF-β treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: A model for human scleroderma
- (1999) J. Immunol , vol.163 , pp. 5693-5699
- McCormick, L.L.¹ Zhang, Y.² Tootell, E.³ Gilliam, A.C.⁴

35
- 0032790562
- Collagen fiber orientation as quantified by small angle light scattering in wounds treated with transforming growth factor-β2 and its neutalizing antibody
- (1999) Wound Repair Regen , vol.7 , pp. 179-186
- Bowes, L.E.¹ Jimenez, M.C.² Hiester, E.D.³ Sacks, M.S.⁴ Brahmatewari, J.⁵ Mertz, P.⁶ Eaglstein, W.H.⁷

36
- 0031656012
- Evidence that TGF-β should be a therapeutic target in diabetic nephropathy
- (1998) Kidney Int , vol.54 , pp. 1390-1391
- Border, W.A.¹ Noble, N.A.²

37
- 0026562550
- Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor
- (1992) J. Exp. Med , vol.175 , pp. 1413-1416
- Johnson, R.J.¹ Raines, E.W.² Floege, J.³ Yoshimura, A.⁴ Pritzl, P.⁵ Alpers, C.⁶ Ross, R.⁷

38
- 0035034653
- Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis
- (2001) J. Am. Soc. Nephrol , vol.12 , pp. 909-918
- Ostendorf, T.¹ Kunter, U.² Grone, H.J.³ Bahlmann, F.⁴ Kawachi, H.⁵ Shimizu, F.⁶ Koch, K.M.⁷ Janjic, N.⁸ Floege, J.⁹

39
- 1842411863
- Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
- (1997) J. Clin. Invest , vol.99 , pp. 1380-1389
- Hocher, B.¹ Thone-Reineke, C.² Rohmeiss, P.³ Schmager, F.⁴ Slowinski, T.⁵ Burst, V.⁶ Siegmund, F.⁷ Quertermous, T.⁸ Bauer, C.⁹ Neumayer, H.H.¹⁰

40
- 0034120477
- An oral endothelin-A receptor antagonist blocks collagen synthesis and deposition in advanced rat liver fibrosis
- (2000) Gastroenterology , vol.118 , pp. 1169-1178
- Cho, J.J.¹ Hocher, B.² Herbst, H.³ Jia, J.D.⁴ Ruehl, M.⁵ Hahn, E.G.⁶ Riecken, E.O.⁷ Schuppan, D.⁸

41
- 0035069742
- Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function
- (2001) Kidney Int , vol.59 , pp. 1333-1341
- Forbes, J.M.¹ Hewitson, T.D.² Becker, G.J.³ Jones, C.L.⁴

42
- 0033802165
- Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis
- (2000) Kidney Int , vol.58 , pp. 1389-1399
- Gupta, S.¹ Clarkson, M.R.² Duggan, J.³ Brady, H.R.⁴

43
- 0035815683
- CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling
- (2001) J. Biol. Chem , vol.276 , pp. 10594-10601
- Holmes, A.¹ Abraham, D.J.² Sa, S.³ Shiwen, X.⁴ Black, C.M.⁵ Leask, A.⁶

44
- 0035476418
- Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy
- (2001) Biochem. J , vol.359 , pp. 77-87
- Wahab, N.A.¹ Yevdokimova, N.² Weston, B.S.³ Roberts, T.⁴ Li, X.J.⁵ Brinkman, H.⁶ Mason, R.M.⁷

45
- 0034817102
- Role of connective tissue growth factor in profibrotic action of transforming growth factor-β: A potential target for preventing renal fibrosis
- (2001) Am. J. Kidney Dis , vol.38
- Yokoi, H.¹ Sugawara, A.² Mukoyama, M.³ Mori, K.⁴ Makino, H.⁵ Suganami, T.⁶ Nagae, T.⁷ Yahata, K.⁸ Fujinaga, Y.⁹ Tanaka, I.¹⁰

46
- 0034072219
- Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis
- (2000) Kidney Int , vol.57 , pp. 1493-1501
- Peters, H.¹ Border, W.A.² Noble, N.A.³

47
- 0035204325
- Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage
- (2001) J. Am. Soc. Nephrol , vol.12 , pp. 2572-2584
- Amann, K.¹ Simonaviciene, A.² Medwedewa, T.³ Koch, A.⁴ Orth, S.⁵ Gross, M.L.⁶ Haas, C.⁷ Kuhlmann, A.⁸ Linz, W.⁹ Scholkens, B.¹⁰ Ritz, E.¹¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.